Drug Shortage Report for PMS-ALENDRONATE-FC
Report ID | 232411 |
Drug Identification Number | 02284006 |
Brand name | PMS-ALENDRONATE-FC |
Common or Proper name | ALENDRONATE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-07-07 |
Estimated end date | 2024-11-08 |
Actual end date | 2024-11-26 |
Shortage status | Resolved |
Updated date | 2024-11-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-11-27 | French | Compare |
v11 | 2024-11-27 | English | Compare |
v10 | 2024-09-30 | French | Compare |
v9 | 2024-09-30 | English | Compare |
v8 | 2024-09-12 | French | Compare |
v7 | 2024-09-12 | English | Compare |
v6 | 2024-08-23 | French | Compare |
v5 | 2024-08-23 | English | Compare |
v4 | 2024-08-05 | French | Compare |
v3 | 2024-08-05 | English | Compare |
v2 | 2024-07-08 | French | Compare |
v1 | 2024-07-08 | English | Compare |
Showing 1 to 12 of 12